Wolverine Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-4,653
Closed -$16.4K – 1685
2023
Q4
$16.4K Sell
4,653
-3,000
-39% -$8.61K ﹤0.01% 1342
2023
Q3
$19.8K Sell
7,653
-1,355
-15% -$4.76K ﹤0.01% 1362
2023
Q2
$35.5K Sell
9,008
-936
-9% -$2.97K ﹤0.01% 1213
2023
Q1
$33.6K Buy
9,944
+1,510
+18% +$6.16K ﹤0.01% 1265
2022
Q4
$30.2K Sell
8,434
-2,000
-19% -$8.55K ﹤0.01% 1460
2022
Q3
$42K Buy
10,434
+888
+9% +$4.56K ﹤0.01% 1636
2022
Q2
$42K Buy
9,546
+206
+2% +$1.49K ﹤0.01% 1612
2022
Q1
$79K Buy
9,340
+1,143
+14% +$8.03K ﹤0.01% 1376
2021
Q4
$72K Buy
8,197
+587
+8% +$5.58K ﹤0.01% 1442
2021
Q3
$79K Buy
7,610
+4,259
+127% +$37.2K ﹤0.01% 1338
2021
Q2
$35K Buy
3,351
+2,851
+570% +$28.1K ﹤0.01% 1765
2021
Q1
$5K Sell
500
-94,923
-99% -$1.32M ﹤0.01% 1924
2020
Q4
$1.06M Sell
95,423
-176,780
-65% -$1.8M 0.01% 634
2020
Q3
$2.73M Buy
272,203
+171,203
+170% +$1.73M 0.02% 342
2020
Q2
$1.01M Buy
+101,000
New +$992K 0.01% 545

Other funds holding SRTA

Wolverine Asset Management's SRTA Position: Q1 2024 in Review

Wolverine Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2024, closing a stake of 4,653 shares — an estimated $16.4K sold.

Wolverine Asset Management first reported a position in SRTA in Q2 2020 and held it in 15 quarters. The position peaked at $2.73M in Q3 2020. 114 funds tracked by Wall St. Rank hold SRTA as of Q1 2024.

  • Wolverine Asset Management reported no remaining Strata Critical Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 4,653 Strata Critical Medical Inc shares in Q1 2024, an estimated $16.4K.
  • Wolverine Asset Management first reported a position in Strata Critical Medical Inc in Q2 2020 and held it in 15 quarters.
  • Wolverine Asset Management's Strata Critical Medical Inc position peaked at $2.73M in Q3 2020.
  • 114 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.